From Our Print Archives

Early Recognition and Risk Assessment of the Septic Patient: Part Two

View Comments (3)Print ArticleEmail Article
The Tools That Enable Early Sepsis Diagnosis and Risk Assessment
The Value of Setting an Early Procalcitonin Baseline in Continuous Risk Assessment

Early recognition of sepsis is vital to survival. While measuring procalcitonin (PCT) levels is not considered a replacement for lactate, PCT can frequently provide one of the earliest clinical clues of sepsis risk. In this presentation, Dr. Amin and Dr. Haire will discuss their hospital's sepsis protocol, which involves an initial PCT test in the emergency department and subsequent testing in the ICU to establish a baseline so that risk assessment can continue in the first 24 hours after a patient is admitted.

Overview of series
Early Recognition and Risk Assessment of the Septic Patient: A Two-Part Series

Sepsis can be defined as the body's reaction to infection (bacterial, viral, fungal, parasitic) which may lead to a systemic inflammatory reaction and eventually organ dysfunction and/or failure.

According to the CDC, the number of hospitalizations from sepsis has more than doubled between 2000 and 2008, resulting in much longer, costlier hospitals stays and more fatal outcomes for patients with bloodstream infections. The incidence of severe sepsis and septic shock are on the rise. Sepsis is a leading cause of mortality in the U.S. According the CDC, sepsis impacts 750,000 patients annually in the U.S.; 30-50 percent of these patients do not survive. In fact, Severe sepsis takes more lives than breast, colon/rectal, pancreatic, and prostate cancer combined.

Rapid diagnosis of sepsis, followed quickly by early intervention with IV fluids, vasopressor therapy and antibiotics is the gold-standard approach. Early diagnosis and intervention saves lives.

This webinar series will:

  • Provide an update on legislative efforts to introduce evidence-based protocols for early recognition
  • Demonstrate the value of lactate and PCT testing in patient suspected of sepsis
  • Show how taking the first PCT test in the ED can provide ongoing risk assessment within the first 24 hours after admission
  • Illustrate why PCT is additive to current Sepsis assessment tools

Our speakers will take part in an interactive Q&A session. Come prepared with your questions about early diagnosis and risk assessment in the septic patient.


Information collected during registration may be shared with the sponsors.

For more information about our sponsors, please visit:

www.biomerieux-usa.com

Sponsored by

Featured Speakers

Devendra N. Amin, MD, MBBS, FCCP

Director of Critical Care Services, Morton Plant Hospital

Stephen Haire, MD

Chair, Dept. Emergency Medicine, Medical Dir. Morton Plant Emergency Dept., & Chair, Pinellas Co. Medical Control Board


 

Very Good information.

Dyman  Conner March 07, 2014
Irving , TX



I LISTENED TO THIS WEBINAR TWICE NOW AND RECEIVED ALOT OF GOOD INFORMATION.

Susan  Neubauer January 05, 2014
Lockport , NY



VERY GOOD TALK

Susan  Neubauer January 02, 2014
Lockport , NY




     

Email: *

Email, first name, comment and security code are required fields; all other fields are optional. With the exception of email, any information you provide will be displayed with your comment.

First * Last
Name:
Title Field Facility
Work:
City State
Location:

Comments: *
To prevent comment spam, please type the code you see below into the code field before submitting your comment. If you cannot read the numbers in the below image, reload the page to generate a new one.

Captcha
Enter the security code below: *

Fields marked with an * are required.

 
http://shop.advanceweb.com/clearance.html
http://www.yourcommunityhospital.com
http://www.quickslide.com